Zobrazeno 1 - 10
of 256
pro vyhledávání: '"Kenichi, Matsuo"'
Autor:
Tsuneyuki Uchida, Ryuichi Sekine, Kenichi Matsuo, Gaku Kigawa, Takahiro Umemoto, Mikio Makuuchi, Kuniya Tanaka
Publikováno v:
BMC Surgery, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Day of the week when elective gastrointestinal surgery is performed may be influenced by various background and tumor-related factors. Relationships between postoperative outcome and when in the week gastrectomy is performed remai
Externí odkaz:
https://doaj.org/article/f8cedfcdf2b744c4bcedc5c5ae82856c
Publikováno v:
Surgical Case Reports, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract Background Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) has been advocated for treating advanced liver tumors, but the devascularized ischemic area resulting from liver parenchymal division can become a
Externí odkaz:
https://doaj.org/article/d8cdeed197f143f5bc88565786837431
Autor:
Yuki Takahashi, Kenichi Matsuo, Hideyuki Oyama, Ryuichi Sekine, Akihiro Nakamura, Tsuneyuki Uchida, Mikio Makuuchi, Kuniya Tanaka
Publikováno v:
Surgical Case Reports, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract Background Pancreatoduodenectomy including resection of the superior mesenteric vein (SMV) is increasingly performed for right-sided pancreatic ductal adenocarcinoma invading the wall of that vessel. Various venous grafts may be chosen for r
Externí odkaz:
https://doaj.org/article/78427c3a66844b8da125f36178bffae2
Autor:
Akihiro Nakamura, Yuki Takahashi, Kenichi Matsuo, Hideyuki Oyama, Ryuichi Sekine, Tsuneyuki Uchida, Mikio Makuuchi, Kuniya Tanaka
Publikováno v:
The Showa University Journal of Medical Sciences. 35:19-24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40400b1ae07a531c80460e39c5d8be33
https://doi.org/10.15369/sujms.35.19
https://doi.org/10.15369/sujms.35.19
Autor:
Tsuneyuki Uchida, Ryuichi Sekine, Kenichi Matsuo, Gaku Kigawa, Takahiro Umemoto, Kuniya Tanaka
Publikováno v:
Clinical Nutrition. 41:1467-1474
Preoperative low skeletal muscle mass and obesity have been identified as poor prognostic factors after gastrectomy for cancer, but the predictive value of combined quantitation of skeletal muscle mass and obesity remains unclear. This study examined
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1c5332ab62c73c8739545c789473be8
https://doi.org/10.1016/j.clnu.2022.05.002
https://doi.org/10.1016/j.clnu.2022.05.002
Autor:
Kenichi Matsuo, Masayoshi Fukuoka, Yayoi Takao, Khoon Tee Chong, Junko Taguchi, Hitoshi Miyakoshi, Seiji Miyahara, Eiji Matsushima, Kunihiro Yoshisue, Akio Fujioka, Keisuke Yamamura, Takeshi Wakasa, Tatsushi Yokogawa, Wakako Yano
Median survival times in a CFPAC-1 peritoneal dissemination model after S-1, TAS-114, or S-1 and TAS-114 combination treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f60cdf7d0cd216ad12f8c357b4c534c0
https://doi.org/10.1158/1535-7163.22505167
https://doi.org/10.1158/1535-7163.22505167
Autor:
Kazutaka Miyadera, Kenichi Matsuo, Satoru Ito, Katsumasa Nonoshita, Gotaro Tanaka, Hirokazu Ohsawa, Akihiro Hashimoto, Takashige Okayama, Yuichiro Ohe, Yoshimi Aoyagi, Haruyasu Murakami, Masanori Kato, Makoto Nishio, Kimihiro Ito
TAS-121 is a novel orally active selective covalent inhibitor of the mutant EGFR. We performed preclinical characterization of TAS-121 and compared its efficacy and selectivity for common EGFR mutations (Ex19del and L858R), first- and second- generat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::805194b35c0d3494950f2385fd2c8800
https://doi.org/10.1158/1535-7163.c.6539667
https://doi.org/10.1158/1535-7163.c.6539667
Autor:
Kazutaka Miyadera, Kenichi Matsuo, Satoru Ito, Katsumasa Nonoshita, Gotaro Tanaka, Hirokazu Ohsawa, Akihiro Hashimoto, Takashige Okayama, Yuichiro Ohe, Yoshimi Aoyagi, Haruyasu Murakami, Masanori Kato, Makoto Nishio, Kimihiro Ito
Supplementary Table S2 shows the case reports of clinical activity and AUC0-24h of TAS-121.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::752a7fc327fe13a7669a6a754c8415e4
https://doi.org/10.1158/1535-7163.22510620.v1
https://doi.org/10.1158/1535-7163.22510620.v1
Autor:
Kenichi Matsuo, Kazuhiko Yonekura, Yoshimi Aoyagi, Kazutaka Miyadera, Renu Wadhwa, Takashige Okayama, Kenji Tanaka, Ryoto Fujita, Akihiro Hashimoto, Hirokazu Ohsawa, Takao Uno, Naomi Abe, Miki Terasaka, Shinichi Hasako
Body weight change resulting from once-daily oral administration of TAS6417
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19a476858e30bac48361a3b8a662fca9
https://doi.org/10.1158/1535-7163.22504678
https://doi.org/10.1158/1535-7163.22504678
Autor:
Kenichi Matsuo, Shuichi Ohkubo, Renu Wadhwa, Tadashi Shimamura, Yuichi Kawai, Hikari Araki, Kaoru Funabashi, Kenji Tanaka, Hirokazu Ohsawa, Akihiro Hashimoto, Akio Fujioka, Kei Oguchi, Yayoi Fujioka, Kimihiro Ito, Hiroki Irie
Activated HER2 is a promising therapeutic target for various cancers. Although several reports have described HER2 inhibitors in development, no covalent-binding inhibitor selective for HER2 has been reported. Here, we report a novel compound TAS0728
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9557f3e6055579f404ae14fec7e4b96
https://doi.org/10.1158/1535-7163.c.6538552.v1
https://doi.org/10.1158/1535-7163.c.6538552.v1